Brief: Dermata Therapeutics - To Launch First Commercial Product Tome Foundational Treatment On August 25, 2026
11/08/2026 22:10
BRIEF-Dermata Therapeutics - To Launch First Commercial Product Tome Foundational Treatment On August 25, 2026 Aug 11 (Reuters) - Dermata Therapeutics Inc DRMA.O:
DERMATA THERAPEUTICS - TO LAUNCH FIRST COMMERCIAL PRODUCT TOME FOUNDATIONAL TREATMENT ON AUGUST 25, 2026 - SEC FILING
Further company coverage: DRMA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dermata Therapeutics
See all newsNASDAQ RESUMED AT 10:31 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:26 AM
Brief: Dermata Therapeutics - To Launch First Commercial Product Tome Foundational Treatment On August 25, 2026
Dermata Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dermata Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview